New Once-A-Month Postmenopausal Osteoporosis Drug Available

Tags:
Actonel Fda Once Month Osteoporosis Therapy Prevent Spinal Fracture, Postmenopausal Women

Add video views to your Facebook Timeline:

Recently, the U.S. Food and Drug Administration (FDA) approved a new once-a-month dose of Actonel® (risedronate sodium) tablets making it the only oral once-a-month osteoporosis therapy approved to help prevent both spinal and non-spinal fractures in postmenopausal women. The new once-a-month dose of Actonel is available for patients seeking the fracture protection of Actonel in the convenience of one monthly pill. In addition to being approved to help protect the spine from fractures, Actonel is also approved to help prevent non-spinal fractures, measured as a group, namely the hip, wrist, collar bone, arm, pelvis, and leg.

  1. By: NewsInfusion
  2. Categories Science & Tech
  3. Views 139
  4. Added :17-Jun-08
Comments on New Once-A-Month Postmenopausal Osteoporosis Drug Available
Other comments on this video 0 Comments
 

Up Next: Binary Domain -- Exclusive Multiplayer Trailer